U.S. Markets closed

Numinus Wellness Inc. (LKYSF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.8410+0.0180 (+2.19%)
At close: 3:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.8158
Open0.8500
BidN/A x N/A
AskN/A x N/A
Day's Range0.8100 - 0.8500
52 Week Range0.5900 - 1.5300
Volume130,452
Avg. Volume514,714
Market Cap168.881M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1000
Earnings DateApr 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Ketamine One Highlights Psychedelic Research and Announces New Clinical Trial
    GlobeNewswire

    Ketamine One Highlights Psychedelic Research and Announces New Clinical Trial

    KGK Science Is Working With Psychedelics Companies, Pharmaceutical Enterprises and Analytical Labs to Expand Ketamine One’s Mental Health PlatformVANCOUVER, British Columbia, June 17, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments and associated research, is pleased to provide guidance on several new

  • “The Science Behind Using Psychedelics To Treat Mental Health Disorders And Addiction Is Compelling”
    GlobeNewswire

    “The Science Behind Using Psychedelics To Treat Mental Health Disorders And Addiction Is Compelling”

    Jim Cramer discussed psychedelics on his June 15, 2021 program and said big drug companies tried, and failed, to treat major depression. Here are four psychedelic companies you need to know about that are addressing the mental health crisis.OTCStockReview.com News Commentary ATLANTA, June 16, 2021 (GLOBE NEWSWIRE) -- Jim Cramer discussed psychedelics on his June 15, 2021 program and said, “The science behind using psychedelics to treat mental health disorders and addiction is compelling." He als

  • Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation
    CNW Group

    Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation

    Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced the appointments of five experienced leaders to support strategic growth initiatives across the Company's three divisions – Numinus Health, Numinus R&D and Numinus Bioscience.